Skip to main content
. 2019 May 24;19:494. doi: 10.1186/s12885-019-5675-4

Fig. 1.

Fig. 1

INNOVATION Study (Version 4.1) flow chart. CapOx: Capecitabine, Oxaliplatin; mFOLFOX 6: Modified FOLFOX 6; FLOT: 5-fluorouracil (FU), Leucovorin, Oxaliplatin and Taxotere; CisPT: Cisplatin; Cape: Capecitabine; Her-2: Human epidermal growth factor receptor type 2; GE-junction: Gastroesophageal junction; w: weeks